EMA QA Document for the Implementation of the Variations Guidelines
Recommendation

6/7 October 2026
The European Medicines Agency (EMA) has published a document with practical questions and answers to support the implementation of the variations guidelines in the centralised procedure. The Q&A Document provides practical considerations concerning the implementation of the various categories of variations, on the operation of the respective procedures and on the documentation to be submitted pursuant to those procedures (the 'variations guidelines')
The questions are organised into the following themes:
- general consideration
- new classification category C.1.11
- new classification category C.1.13
- impact on post-authorisation measure (PAM) submissions
- revised classification category C.I.8
- new classification category A.8
Source: EMA/427505/2013 Rev.1
Related GMP News
12.08.2026When Training Fails: FDA Warning Letters Highlight GMP Training Deficiencies in 2026
29.07.2026EU-GMP for Veterinary Medicinal Products: What will change in Switzerland?
15.07.2026Root Cause Analysis and CAPA: Two more Warning Letters issued to Companies in Europe
01.07.2026EMA publishes updated Q&A on EU-US MRA - Veterinary Medicinal Products now fully covered
24.06.2026Reduced Testing a Matter of GMP or Specification?
17.06.2026FDA adopts updated ICH Q8/Q9/Q10 Questions & Answers (R5)


